Humira(CF) 40 MG/0.4 ML syrings
Ended Awarded
- Contract number
- SPE2DR26FCL2R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,406
Award facts
- Contract value 100% obligated
- $11,406.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) 40 mg/0.4 ml syringes under a firm fixed-price contract valued at $11,406.48. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025, and involves performance at the contractor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and represents a child contract issued against AmerisourceBergen Drug Corp's larger prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency programs and other government healthcare systems worldwide. This delivery order for HUMIRA, a widely used immunosuppressant medication, exemplifies the company's role in supplying brand-name pharmaceuticals across multiple therapeutic domains to federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FCL2R?
SPE2DR26FCL2R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FCL2R worth?
The government has obligated $11,406 on SPE2DR26FCL2R.
Is contract SPE2DR26FCL2R an order under another contract?
Yes. SPE2DR26FCL2R is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCL2R competed?
The extent of competition for SPE2DR26FCL2R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award